1-7 of 7
Mar Tormo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML

Clinical Trials & Observations
Amer M. Zeidan, Isaac Boss, C. L. Beach, Wilbert B. Copeland, Ethan Thompson, Brian A. Fox, Vanessa E. Hasle, Andrzej Hellmann, David C. Taussig, Mar Tormo, Maria Teresa Voso, James Cavenagh, Tim O’Connor, Alessandro Previtali, Shelonitda Rose, Lewis R. Silverman
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2219–2229.
https://doi.org/10.1182/bloodadvances.2021006138
Published: 2022
Includes: Supplemental data
Journal Articles

A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for higher-risk myelodysplastic syndromes

Clinical Trials & Observations
Amer M. Zeidan, Isaac Boss, C. L. Beach, Wilbert B. Copeland, Ethan Thompson, Brian A. Fox, Vanessa E. Hasle, Ken Ogasawara, James Cavenagh, Lewis R. Silverman, Maria Teresa Voso, Andrzej Hellmann, Mar Tormo, Tim O’Connor, Alessandro Previtali, Shelonitda Rose, Guillermo Garcia-Manero
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2207–2218.
https://doi.org/10.1182/bloodadvances.2021005487
Published: 2022
Includes: Supplemental data
Journal Articles

Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study

Clinical Trials & Observations
David Martínez-Cuadrón, Juan E. Megías-Vericat, Josefina Serrano, Pilar Martínez-Sánchez, Eduardo Rodríguez-Arbolí, Cristina Gil, Eliana Aguiar, Juan Bergua, José L. López-Lorenzo, Teresa Bernal, Ana Espadana, Mercedes Colorado, Carlos Rodríguez-Medina, María López-Pavía, Mar Tormo, Lorenzo Algarra, María-Luz Amigo, María J. Sayas, Jorge Labrador, Juan I. Rodríguez-Gutiérrez, Celina Benavente, Lissette Costilla-Barriga, Raimundo García-Boyero, Esperanza Lavilla-Rubira, Susana Vives, Pilar Herrera, Daniel García-Belmonte, María Mar Herráez, Graça Vasconcelos Esteves, Maria I. Gómez-Roncero, Ana Cabello, Guiomar Bautista, Amaia Balerdi, José Mariz, Blanca Boluda, Miguel Á. Sanz, Pau Montesinos
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1278–1295.
https://doi.org/10.1182/bloodadvances.2021005335
Published: 2022
Includes: Supplemental data
Journal Articles

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol

Alex Bataller, Ana Garrido, Francesca Guijarro, Guadalupe Oñate, Marina Diaz-Beyá, Montserrat Arnan, Mar Tormo, Susana Vives, María Paz Queipo de Llano, Rosa Coll, David Gallardo, Ferran Vall-Llovera, Lourdes Escoda, Antonio Garcia-Guiñon, Olga Salamero, Antònia Sampol, Brayan M. Merchan, Joan Bargay, Sandra Castaño-Díez, Daniel Esteban, Aina Oliver-Caldés, Andrea Rivero, Pablo Mozas, Mònica López-Guerra, Marta Pratcorona, Lurdes Zamora, Dolors Costa, Maria Rozman, Josep F. Nomdedéu, Dolors Colomer, Salut Brunet, Jorge Sierra, Jordi Esteve,
Journal: Blood Advances
Blood Adv (2022) 6 (4): 1193–1206.
https://doi.org/10.1182/bloodadvances.2021005585
Published: 2022
Includes: Supplemental data
Journal Articles

Prognostic impact of DNMT3A mutation in acute myeloid leukemia with mutated NPM1

Clinical Trials & Observations
Guadalupe Oñate, Alex Bataller, Ana Garrido, Montserrat Hoyos, Montserrat Arnan, Susana Vives, Rosa Coll, Mar Tormo, Antònia Sampol, Lourdes Escoda, Olga Salamero, Antoni Garcia, Joan Bargay, Alba Aljarilla, Josep F. Nomdedeu, Jordi Esteve, Jorge Sierra, Marta Pratcorona
Journal: Blood Advances
Blood Adv (2022) 6 (3): 882–890.
https://doi.org/10.1182/bloodadvances.2020004136
Published: 2022
Includes: Supplemental data
Journal Articles

Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19

Clinical Trials & Observations
José Luis Piñana, Ramon Garcia-Sanz, Rodrigo Martino, María Garcia-Roa, Gabriel Andrés Martin-Martin, Irene Risco-Gálvez, Mar Tormo, Pilar Martinez-Barranco, Sara Marcos-Corrales, Marisa Calabuig, Venancio Conesa, Anabel Teruel, Sara Ruiz-Pérez, Carlos Solano, David Navarro, Ángel Cedillo, Anna Sureda,
Journal: Blood Advances
Blood Adv (2022) 6 (3): 848–853.
https://doi.org/10.1182/bloodadvances.2021006326
Published: 2022
Includes: Supplemental data
Journal Articles

Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial

Clinical Trials & Observations
Catia Simoes, Bruno Paiva, David Martínez-Cuadrón, Juan-Miguel Bergua, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose-Luis Lopez, Maria-Belen Vidriales, Jorge Labrador, Jose-Francisco Falantes, María-José Sayas, Rosa Ayala, Joaquin Martinez-Lopez, Sara Villar, Maria-Jose Calasanz, Felipe Prosper, Jesús F. San-Miguel, Miguel Ángel Sanz, Pau Montesinos
Journal: Blood Advances
Blood Adv (2021) 5 (3): 760–770.
https://doi.org/10.1182/bloodadvances.2020003195
Published: 2021
Includes: Supplemental data